Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy

To the Editor: Pembrolizumab and nivolumab, two humanized antibodies against programmed cell death 1 (PD-1) receptor, were recently approved for the treatment of unresectable or metastatic melanoma and for other cancers. We report two cases of severe demyelinating polyradiculoneuropathy that…

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2aejix9
via IFTTT